And Pfizer and Roche have multiple oral candidates taken in pill form
CRC Press, Boca Raton, Florida
Key Players of the GLP-1 Companion Products Market Nestle Health Science Herbalife Abbott Laboratories Conagra Brands Huel Glanbia Nutritionals Orgain Thorne HealthTech FrieslandCampina Ingredients Arla Foods Ingrdients Specialty Enzymes & Probiotics Recent Industry Developments Arla Foods Ingredients targets GLP-1 companion nutrition at Vitafoods Europe (2026), Arla Foods Ingredients has developed new solutions to meet the needs of users of GLP-1 anti-obesity medications
a 30 day bundle format with flavour choice for Electrolyte+
Some potential side effects may include: Mild injection site irritation Temporary water retention (rare) Increased hunger (via IGF-1 signaling) Vivid dreams (due to improved deep sleep) Fatigue or lethargy if overdosed Caution: Do not use in individuals with active or suspected cancer, as GH and IGF-1 can stimulate cell growth
It is not intended for human consumption, diagnostic use, or therapeutic treatment